Piloting the global subsidy: The impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Sabot, Oliver J ^a   Mwita, Alex ^b   Cohen, Justin M ^a   Ipuge, Yahya ^c   Gordon, Megumi ^a   Bishop, David ^d   Odhiambo, Moses ^e   Ward, Lorrayne ^f   Goodman, Catherine ^g  

^a Clinton Foundation HIV/AIDS Initiative   (United States)

^b MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^c Tanzania Country Office   (Tanzania)

^d MOTT MACDONALD   (United Kingdom)

^e Social Research Division   (Kenya)

^f HARVARD UNIVERSITY   (United States)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; FANSIDAR; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ADULT; ARTICLE; CHILD; CONSUMER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG COST; DRUG MARKETING; DRUG USE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALARIA; PILOT STUDY; RURAL AREA; TANZANIA; COMMERCIAL PHENOMENA; DRUG COMBINATION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH; HEALTH CARE DELIVERY; INTERVENTION STUDY; METHODOLOGY; ORGANIZATION AND MANAGEMENT; RURAL POPULATION; STATISTICS;

ANTIMALARIALS; ARTEMISININS; COMMERCE; DRUG COMBINATIONS; DRUG COSTS; ETHANOLAMINES; FINANCING, GOVERNMENT; FLUORENES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERVENTION STUDIES; MALARIA; PILOT PROJECTS; PRIVATE SECTOR; PYRIMETHAMINE; RURAL HEALTH; RURAL POPULATION; SULFADOXINE; TANZANIA;

EID: 70149090146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006857     Document Type: Article

References (22)

1. World Health Organization (2006) Guidelines for the treatment of malaria. Geneva: World Health Organization.
2. Laxmanarayan R, Over M, Smith D (2006) Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? Health Affairs 25:2: 325-6.
3. World Health Organization (2008) World Malaria Report 2008. Geneva: World Health Organization.
4. Cohen JM, Singh I, O'Brien M (2008) Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies. Malaria Journal 7:200.
5. McCombie SC (1996) Treatment seeking for malaria: A review of recent research. Social Science & Medicine 43:6: 933-945.
6. UNICEF, Roll Back Malaria Partnership (2007) Malaria and children: progress in intervention coverage. New York: UNICEF.
7. '7 Kachur SP, Black C, Abdulla S, Goodman C (2006) Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malaria Journal 5:25.
8. Medicines for Malaria Venture (2008) Understanding the antimalarial market: Uganda 2007. Geneva: Medicines for Malaria Venture.
9. Rehwagen C (2006) WHO ultimatum on artemisinin monotherapy is showing results. BMJ 332: 1176.
10. Arrow K, Panosian C, Gelband H, eds (2004) Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington D.C.: Institute of Medicine, National Academies Press.
11. Oxfam International (2009) Blind optimism: Challenging the myths about private health care in poor countries. London, England: Oxfam International.
12. Tanzania National Bureau of Statistics (2004) 2002 Population and Housing Census General Report. Dar es Salaam: Government of Tanzania.
13. Goodman C, Kachur SP, Abdulla S, et al. (2004) Retail supply of malaria-related drugs in rural Tanzania: Risks and opportunities. Tropical Medicine and International Health 9:6: 655-663.
14. Tanzania Food and Drug Authority (2007) Register of Duka la Dawa Baridi in Tanzania Mainland. Dar es Salaam: Government of Tanzania.
15. Roll Back Malaria Partnership (2007) Technical Design of the Affordable Medicines Facility - malaria. Geneva.
16. Robinson JC, Luft HS (1987) Competition and the cost of hospital care: 1972 to 1982. Journal of the American Medical Association 257: 3241-3245.
17. Tanzania Commission for AIDS (TACAIDS), National Bureau of Statistics (NBS), and ORC Macro 2005 (2006) Tanzania HIV/AIDS Indicator Survey 2003-04. Calverton, Maryland, USA: TACAIDS, NBS, and ORC Macro.
18. Tanzania Ministry of Health and Social Welfare (2006) National guidelines for malaria diagnosis and treatment 2006. Dar es Salaam: Government of Tanzania.
19. Wolf K, Derriennic Y (2005) Costing artemisinin-based combination therapy in Tanzania. Bethesda, Maryland: Abt Associates.
20. Worrall E, Basu S, Hanson K (2005) Is malaria a disease of poverty? A review of the literature. Tropical Medicine and International Health 10:10: 1047-059.
21. Chen A, Ward L, Sabot O (2008) Review of the private sector anti-malarial market in Tanzania. Boston: Clinton Foundation HIV/AIDS Initiative.
22. Australian Government (2006) Arrangements for the Operation of the Community Service Obligation (CSO) Funding Pool, Guidelines. Canberra: Government of Australia.